US Patent Issued to DANA-FARBER CANCER INSTITUTE, THE BRIGHAM AND WOMEN'S HOSPITAL, MEDICAL UNIVERSITY OF LODZ on Aug. 12 for "Circulating microrna signatures for ovarian cancer" (Polish, American Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,385,099, issued on Aug. 12, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston), THE BRIGHAM AND WOMEN'S HOSPITAL INC. (Boston) and MEDICAL UNIVERSITY OF LODZ (Lods, Poland).

"Circulating microrna signatures for ovarian cancer" was invented by Dipanjan Chowdhury (Brookline, Mass.), Kevin M. Elias (Brookline, Mass.), Wojciech Fendler (Lodz, Poland) and Konrad Stawiski (Lodz, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods and kits for determining the presence or absence of certain microRNA biomarkers in a blood sample of a female patient. The microRNA biomarkers are associated with ovarian cancer. Also provided ar...